There are 2934 resources available
1872 - Long term follow-up (F/U) report of symptomatic cardiac events (SCEs) in 2,809 breast cancer (BC) patients (pts) treated with adjuvant trastuzumab (T) in real world (RW) practice
Presenter: Serena Di Cosimo
Session: Proffered Paper – Supportive and palliative care
Resources:
Abstract
Slides
Webcast
1883 - EONS - Safe administration of 5-fluorouracil with elastomeric pumps
Presenter: Paul Sessink
Session: EONS 12: Patient safety in cancer care
Resources:
Abstract
Slides
Webcast
2609 - Overall survival (OS) in KATE2, a phase 2 study of programmed death ligand 1 (PD-L1) inhibitor atezolizumab (atezo)+trastuzumab emtansine (T-DM1) vs placebo (pbo)+T-DM1 in previously treated HER2+ advanced breast cancer (BC)
Presenter: Leisha Emens
Session: Proffered Paper - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
Presentation by expert
Presenter: Christoph Klein
Session: Metastasis, dormancy and late recurrence
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Amanda Psyrri
Session: Biomarkers for patient selection for checkpoint inhibitors in HNSCC: Where do we stand?
Resources:
Slides
Webcast
Presentation by expert
Presenter: Sandro Pignata
Session: How to sequence treatment in platinum-sensitive relapsed ovarian cancer
Resources:
Slides
Webcast
Discussion led by Chair
Presenter: Robert Coleman
Session: How to sequence treatment in platinum-sensitive relapsed ovarian cancer
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Anna Sophie Berghoff
Session: WHO grade II and III gliomas: State of the art management
Resources:
Slides
Webcast
Proton therapy for low grade gliomas
Presenter: Frederic Dhermain
Session: WHO grade II and III gliomas: State of the art management
Resources:
Slides
Webcast
Survivorship and delayed effects
Presenter: Anna Sophie Berghoff
Session: WHO grade II and III gliomas: State of the art management
Resources:
Slides
Webcast